The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...

The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration ...

Medicare and Medicaid would cover Ozempic and other popular weight-loss drugs starting in 2026 under a proposed new federal ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...

Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like ...

Millions of Americans are diagnosed with obesity, which is considered a chronic disease that ... adults are overweight or ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.